Metabolically Healthy Obesity: Personalised and Public Health Implications

Trends in Endocrinology and Metabolism

Volumn 27, Issue 4, 2016, Pages 189-191

  Phillips, Catherine M ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Lifestyle; Metabolically healthy obesity; Personalized medicine; Stability: determinants: diet

Indexed keywords

DIAGNOSTIC PROCEDURE; HUMAN; INTERVENTION STUDY; METABOLICALLY BENIGN OBESITY; METABOLICALLY HEALTHY OBESITY; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PHENOTYPE; PHYSICAL ACTIVITY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK FACTOR; SHORT SURVEY; TREATMENT PLANNING; CARDIOVASCULAR DISEASE; METABOLIC SYNDROME X; OBESITY; OBESITY, METABOLICALLY BENIGN; PROGNOSIS; PUBLIC HEALTH;

CARDIOVASCULAR DISEASES; HUMANS; METABOLIC SYNDROME X; OBESITY; OBESITY, METABOLICALLY BENIGN; PROGNOSIS; PUBLIC HEALTH;

EID: 84962611479     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2016.02.001     Document Type: Short Survey

References (15)

1. Kelly T., et al. Global burden of obesity in 2005 and projections to 2030. Int. J. Obes. 2008, 32:1431-1437.
2. Phillips C.M. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev. Endocr. Metab. Disord. 2013, 14:219-227.
3. van Vliet-Ostaptchouk J.V., et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr. Disord. 2014, 14:9.
4. Achilike I., et al. Predicting the development of the metabolically healthy obese phenotype. Int. J. Obes. 2015, 39:228-234.
5. Eshtiaghi R., et al. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study. Int. J. Obes. 2015, 39:514-519.
6. Hamer M., et al. Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. Eur. J. Endocrinol. 2015, 173:703-708.
7. Phillips C.M., Perry I.J. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?. Atherosclerosis 2015, 242:399-406.
8. Jung C.H., et al. The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation. J. Clin. Endocrinol. Metab. 2015, 100:934-941.
9. Guo F., Garvey W.T. Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: stability of metabolic health status in adults. Obesity 2016, 24:516-525.
10. Hinnouho G.M., et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur. Heart J. 2015, 36:551-559.
11. Garvey W.T., et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr. Pract. 2014, 20:977-989.
12. Bell L.K., et al. The relationship between dietary patterns and metabolic health in a representative sample of adult Australians. Nutrients 2015, 7:6491-6505.
13. Camhi S.M., et al. Healthy eating index and metabolically healthy obesity in U.S. adolescents and adults. Prev. Med. 2015, 77:23-27.
14. Phillips C.M., et al. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS ONE 2013, 8:e76188.
15. Schroder H., et al. Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population. Eur. J. Nutr. 2014, 53:1345-1353.